The Foundation for Clinical Research in Inflammatory Bowel Disease announces that it will present Advances in IBD sessions this fall in Hartford, Albany, Wichita and Kansas City. Programs run 6 p.m. until 9 p.m. Registration begins at 5 p.m.

To register for any of these programs, please e-mail
register@myibd.org.

____________

Denver - Thursday, November 12, 2009

Doubletree Hotel Denver
3203 Quebec Street
Denver, CO

Free Parking

Speakers:

David T. Rubin, MD, FACG
Associate Professor of Medicine
Program Director, Fellowship in Gastroenterology, Hepatology and Nutrition
Co-Director, Inflammatory Bowel Disease Center
University of Chicago Medical Center

John S. Sabel, MD, FACG, FACP, AGAF
Chairman, Medical Advisory Committee
Board Member
Rocky Mountain Chapter of the Crohn's & Colitis Foundation of America

Amethyst C. Kurbegov, MD, MPH
Assistant Professor of Pediatrics
Pediatric Gastroenterology, Hepatology, & Nutrition
University of Colorado Denver Health Sciences Center
The Children's Hospital of Denver

____________

Wichita, KS - Tuesday, November 17, 2009

Hyatt Regency Wichita
400 W. Waterman
Wichita, KS 67202

Parking Provided

Faculty:

Sunanda V. Kane, MD, MSPH, FACG
Associate Professor
Mayo Clinic
Division of Gastroenterology and Hepatology

Estephan N. Zayat, MD
Clinical Assistant Professor, Medicine
Internal Medicine/Gastroenterology
KU School of Medicine-Wichita

Mayssa N. Zayat, MD
Preferred Medical Associates
Pediatric Gastroenterologist

____________

Kansas City - Thursday, November 19, 2009

Holiday Inn Hotel & Suites Overland Park West
8787 Reeder Road
Overland Park, KS

Free Parking

Faculty:

Kimberly Persley, MD
Clinical Assistant Professor
University of Texas Southwestern Medical School
Presbyterian Hospital

Mark J. Allen, MD, FACP
Clinical Professor of Medicine
University of Missouri-Kansas City School of Medicine
Mid-America Gastro-Intestinal Consultants, PC

Charles Roberts, MD
Associate Executive Medical Director & Vice President
Professor of Pediatrics
University of Missouri-Kansas City School of Medicine

____________

Advances in Inflammatory Bowel Disease is a free patient education program for anyone affected by Crohn's disease or ulcerative colitis.

Seminars are held throughout the U.S. and feature national and local experts in inflammatory bowel disease (IBD) who discuss the latest information on medical and surgical treatment options.

Patients in Hartford, Conn., learn from Dr. Joshua Korzenik of the Harvard University School of Medicine at an Advances in IBD seminar sponsored by the Foundation for Clinical Research in IBD.

In addition to learning about managing IBD and its complications, participants are invited to ask questions and receive a package of helpful materials.

The value of these seminars was assessed in a study conducted by Hude Quan, M.D., Ph.D., Lloyd R. Sutherland, M.D., and Jane W. Present, Department of Community Health Services, University of Calgary, Canada. Between March 2000 and December 2001, seminar participants from nine communities were asked to fill out a series of questionnaires. The results showed that the seminars not only improve participants’ knowledge of IBD but that participants retain the knowledge they acquire during the seminars.

Armed with up-to-date and accurate information, patients such as these are better able to become active participants in their healthcare.

A full report of the study appeared in the November 2003 issue of the peer-reviewed journal, “Inflammatory Bowel Diseases.”

Click on the links below to read transcripts from the 2005 “Advances in IBD” seminars.

Charlotte, NC
Providence, RI
Boston, MA

Click here to access the monograph prepared to accompany the above programs (Note: PDF file, 3.6 mb, the slides may take a few moments to open, please be patient).

Click here to read a transcript of the 2004 “Advances in IBD” seminars.

This program is supported by sponsorships from Procter & Gamble Pharmaceuticals, Centocor, Shire USA, UCB, Inc., and Axcan Pharma and held in conjunction with the Foundation for Clinical Research in Inflammatory Bowel Disease.